The Luveris In Vitro Fertilization Trial: The Effect of Recombinant Luteinizing Hormone (LH) on Follicular Response, Oocyte Quality, and Pregnancy in In-Vitro Fertilization Treatment Cycles in Women Without Endogenous LH Activity.

Trial Profile

The Luveris In Vitro Fertilization Trial: The Effect of Recombinant Luteinizing Hormone (LH) on Follicular Response, Oocyte Quality, and Pregnancy in In-Vitro Fertilization Treatment Cycles in Women Without Endogenous LH Activity.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2014

At a glance

  • Drugs Lutropin alfa (Primary) ; Follitropin alfa
  • Indications Female infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Dec 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 20 Aug 2012 Planned end date changed from 1 Apr 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov record.
    • 20 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top